People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Healthtech, Biotechnology, Other Technology, Pharmaceuticals, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Route 92 Medical, Inc. | — | Healthtech | Series C | $158.1M | $428.5M | 2016 |
| Silverback Therapeutics, Inc. | — | Biotechnology | Series C | $139.3M | $3.2B | 2020 |
| Edgewise Therapeutics, Inc. | — | Biotechnology | Series C | $120.1M | $3.3B | 2019 |
| Ribon Therapeutics, Inc. | — | Biotechnology | Series B | $119.1M | $342.8M | 2022 |
| Carlsmed, Inc. | — | Biotechnology | Series C | $109.1M | $645.4M | 2022 |
| Sequent Medical, Inc. | — | Other Technology | Series B | $85.3M | $612.1M | 2009 |
| Okami Medical, Inc. | — | Healthtech | Series B | $77.2M | $125.4M | 2019 |
| Sparrow Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $73.3M | $386.2M | 2024 |
| Omada Health, Inc. | — | Other Health Care | Series C | $71.5M | $1.1B | 2014 |
| Inari Medical, Inc. | — | Healthtech | Series B | $51.9M | $669.2M | 2011 |
| Ais Vgp-6, Llc | — | Other | Series A | $45.8M | $16.0M | 2016 |
| HealthJoy, Inc. | — | Healthtech | Series B | $45.5M | $743.5M | 2019 |
| Cleave Biosciences, Inc. | — | Biotechnology | Series B | $37.9M | $475.1M | 2016 |
| Swoop.com, Inc | — | Other | Seed | $11.6M | $55.8M | 2020 |
| Highway 1 Medical, Inc. | — | Healthtech | Pre-Seed | $640K | $10.5M | 2021 |
| El Camino Real Medical, Inc. | — | Healthtech | Pre-Seed | $320K | $5.2M | 2021 |
Jonathan Root at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Root on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Thompson | 4 | 16 |
| Tony Chou | 4 | 7 |
| Jack Lasersohn | 4 | 5 |
| Kirk Nielsen | 2 | 13 |
| Casper De Clercq | 2 | 9 |
| Laura Shawver | 2 | 6 |
| Brian Cox | 2 | 5 |
| Brian J. Cox | 2 | 3 |
| Paul Lubock | 2 | 3 |
| Donald Milder | 2 | 2 |
| Robert Rosenbluth | 2 | 2 |
| Andrew Schwab | 1 | 16 |
| Stuart Larkins | 1 | 14 |
| Cameron Wheeler | 1 | 9 |
| Niall O'Donnell | 1 | 7 |
| Kevin Sidow | 1 | 7 |
| Carol Gallagher | 1 | 6 |
| David Katz | 1 | 6 |
| Klaus Veitinger | 1 | 6 |
| Zach Scheiner | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.